Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome

23 Jan 2024

Abstract excerpt

The coronavirus disease 2019 (COVID-19) pandemic has heavily challenged the global healthcare system. Despite the vaccination programs, the new virus variants are circulating. Further research is required for understanding of the biology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and for discovery of therapeutic agents against the virus. Here, we took advantage of drug repurposing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Image Analysis Techniques
Share to Computational Drug Discovery Methods
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38272320
DOI: 10.1016/j.antiviral.2024.105813

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactomePMID 38272320Read ↗

Virtual screening FDA approved drugs against multiple targets of SARS‐CoV‐2Semantic proximity Read ↗

A Comprehensive Review of Drug Repurposing Strategies against Known Drug Targets of COVID-19Semantic proximity Read ↗

A SARS-CoV-2 protein interaction map reveals targets for drug repurposingSemantic proximity Read ↗

Identification of Drugs Targeting Multiple Viral and Human Proteins Using Computational Analysis for Repurposing Against COVID-19Semantic proximity Read ↗

Repurposing drugs for treatment of SARS-CoV-2 infection: Computational design insights into mechanisms of actionSemantic proximity Read ↗

Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico MethodSemantic proximity Read ↗

Network bioinformatics analysis provides insight into drug repurposing for COVID-19Semantic proximity Read ↗

A Comprehensive SARS-CoV-2 Genomic Analysis Identifies Potential Targets for Drug RepurposingSemantic proximity Read ↗

Identification of potent inhibitors of SARS-CoV-2 infection by combined pharmacological evaluation and cellular network prioritizationSemantic proximity Read ↗

Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19Semantic proximity Read ↗

Drug repurposing for SARS-CoV-2: a high-throughput molecular docking, molecular dynamics, machine learning, and DFT studySemantic proximity Read ↗

Integrated Docking and Enhanced Sampling Based Selection of Repurposing Drugs for SARS-CoV-2 by Targeting Host Dependent FactorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.